OSCAR VELA: Open Payments
NPI 1275740243 · SAN JUAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,745 in 75 payments from 20 companies in 2025. Trend: 2023 $1,720 · 2024 $1,341 · 2025 $1,745
Food & beverage: $1,745
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $420 |
| GlaxoSmithKline, LLC. | 12 | $207 |
| Dexcom, Inc. | 2 | $192 |
| Abbott Laboratories | 1 | $164 |
| Novo Nordisk Inc | 5 | $99 |
| PFIZER INC. | 5 | $97 |
| Paratek Pharmaceuticals, Inc. | 6 | $94 |
| Amgen Inc. | 5 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $45 |
Products named: Dexcom G6 Transmitter, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, FARXIGA, BREZTRI, NUZYRA, LOKELMA, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
